Therapy for Whipple's disease
Open Access
- 10 July 2007
- journal article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 60 (3) , 457-458
- https://doi.org/10.1093/jac/dkm259
Abstract
Whipple's disease was first described in 1907, the genomic composition of the causative organism, Tropheryma whipplei, was unravelled in 2003 and its in vitro susceptibility to antibiotics started to be explored in 2004–05. Still today, this knowledge is not fully applied in the recommendations for the therapy of this disease. In this paper, we summarize the current recommendations on antimicrobial therapy for Whipple's disease and propose a shift in the maintenance therapy.Keywords
This publication has 8 references indexed in Scilit:
- Whipple's DiseaseNew England Journal of Medicine, 2007
- Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic mediumJournal of Antimicrobial Chemotherapy, 2005
- Antibiotic Susceptibility of Tropheryma whipplei in MRC5 CellsAntimicrobial Agents and Chemotherapy, 2004
- Whipple's disease, genomics, and drug therapyThe Lancet, 2003
- Whipple's disease: acquired resistance to trimethoprim-sulfamethoxazoleAmerican Journal of Gastroenterology, 2000
- Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapyJournal of Antimicrobial Chemotherapy, 1996
- Short-Term Antibiotic Treatment in Whipple’s DiseaseJournal of Clinical Gastroenterology, 1991
- Antibiotic treatment and relapse in Whipple's diseaseGastroenterology, 1985